An interventional study of Fractal Cueing and Isochronous Cueing in Anterior Cruciate Ligament Reconstruction, Anterior Cruciate Ligament Reconstruction Rehabilitation and Athlete, sponsored by Egas Moniz - Cooperativa de Ensino Superior, CRL. Recruiting at 1 site in Portugal. Open to participants aged 15 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-09-11.
Sponsored by Egas Moniz - Cooperativa de Ensino Superior, CRL · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Anterior cruciate ligament (ACL) injuries are among the most prevalent and functionally limiting knee injuries in sports, particularly those that involve pivoting movements. Despite advancements in surgical reconstruction and physical rehabilitation, many athletes continue to exhibit persistent motor control deficits and increased gait variability, both of which are closely linked to a heightened risk of re-injury and long-term joint degeneration. These deficits arise from biomechanical impairments and disrupt proprioceptive input that requires cortical reorganization, contributing to maladaptive neuroplasticity. However, conventional rehabilitation strategies often overlook this neural dimension. Recent findings emphasize the importance of fostering motor variability and promoting neuroplasticity through external focus strategies, including sensorimotor synchronization. While isochronous cues, an invariant stimulus, are commonly used, they do not reflect the natural fluctuations of healthy gait and may reduce its complexity. Fractal-based cues, in contrast, introduce structured variability resembling the natural dynamics of locomotion and have been shown to restore gait complexity in clinical populations. However, no study has yet explored their acute effects on gait variability and corticospinal function following ACL reconstruction (ACLR). This crossover randomized controlled trial aims to compare the acute effects of a single session of treadmill walking synchronized to either fractal or isochronous-based visual cues on gait variability and corticospinal measures in athletes with ACLR. The investigators hypothesize that fractal-based cueing will acutely restore gait variability and enhance corticospinal excitability, evidenced by increased corticospinal excitability and intracortical facilitation, and reduced short-interval intracortical inhibition, thus promoting adaptive neuroplasticity. Conversely, isochronous cueing is expected to maintain or decrease gait complexity without improving corticospinal measures. This study may provide insights that could be highly valuable as a way to promote neuroplasticity and optimize gait rehabilitation after ACLR, also allowing an objective quantification and aiming to restore variability to levels close to those observed in healthy individuals, thus contributing to reducing the re-injury rate.
This study will test a laboratory-based intervention using gait trials with sensorimotor synchronization, a common approach in gait rehabilitation aimed at restoring or acutely modifying gait variability. The intervention, called SyncGait, consists of treadmill walking synchronized with visual cues. Following a crossover design, each participant will complete two sessions, one with fractal cueing (FRC) and one with isochronous cueing (ISO), with the order randomized. Each cued trial will last 12 minutes and will be preceded and followed by uncued walking trials. The visual cues will be presented as a moving bar on a screen positioned in front of the treadmill. For the FRC condition, the cues will be individualized to each participant's stride time variability, generated through a fractal algorithm and validated using detrended fluctuation analysis. For the ISO condition, cues will match each participant's average stride time without variability. Participants will be instructed to synchronize heel strikes of the reconstructed limb with the top of the moving bar. The treadmill (Bertec Inc., USA) will record gait data at 1000 Hz. Each session will be conducted individually, supervised by at least two trained team members. A sample size of 36 participants was determined to ensure adequate power (90%) to detect a moderate effect size (ηp² = 0.25) at a 5% significance level, accounting for an anticipated 20% dropout rate. To encourage participation and retention, participants will receive a personalized evaluation report and a free isokinetic assessment within 12 months. Data collection will include both gait and corticospinal outcomes. Gait variability will be analyzed from treadmill force data, focusing on stride intervals and synchronization performance. Corticospinal outcomes will be assessed using transcranial magnetic stimulation (TMS) with a BiStim2 stimulator (Magstim®, UK). Electromyography (Delsys Trigno, AD Instruments, NZ) will be recorded from quadriceps and hamstrings, while knee strength will be assessed with an isokinetic dynamometer (Humac Norm, USA). Standardized electrode placement and contraction protocols will ensure reproducibility. During testing, single- and paired-pulse TMS protocols will be applied at 10% of maximal voluntary contraction. Ten stimuli per condition will be collected, providing reliable estimates of excitability and inhibition. Visual feedback will help participants maintain the required contraction level throughout assessments. Statistical analysis will begin with normality testing (Shapiro-Wilk). Linear mixed models (Time × Cue condition) will be used for primary and secondary outcomes. Post-hoc comparisons will use Bonferroni corrections. Synchronization accuracy will be compared with paired t-tests. Statistical significance will be set at p \< 0.05, and analyses will be performed using Jamovi software. This protocol is designed to rigorously test whether fractal cueing can restore healthy gait variability patterns and enhance corticospinal excitability in athletes with ACL reconstruction, compared with conventional isochronous cueing.
Egas Moniz - Cooperativa de Ensino Superior, CRL is the lead sponsor of 41 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants exposed to 12-minute treadmill walking synchronized to a visual fractal metronome individualized to stride time variability. After a washout period of 1 week, participants will be exposed to 12-minute treadmill walking synchronized to a visual isochronous metronome with fixed stride time.
Device: Fractal Cueing · Device: Isochronous Cueing
Participants exposed to 12-minute treadmill walking synchronized to a visual isochronous metronome with fixed stride time. After a washout period of 1 week, participants will be exposed to 12-minute treadmill walking synchronized to a visual fractal metronome individualized to stride time variability.
Device: Fractal Cueing · Device: Isochronous Cueing
Walking synchronized to a visual fractal metronome.
Walking synchronized to a visual Isochronous metronome.
Gait Variability Measured by Fractal Scaling Exponent of inter-stride intervals
The fractal-scaling exponent, α, of inter-stride intervals (α-ISIs) will be determine by calculating the time between two consecutive heel strikes of the same foot. First, the investigators will identify the heel strike events of the dominant foot. To improve the identification of this event, the signals will be filtered using a 2nd order, zero lag low-pass Butterworth filter with a cutoff frequency of 20 Hz. Then, Detrended Fluctuation Analysis (DFA) will be used to determine the fractal-scaling, an index of complexity. The DFA is a modified random-walk analysis that makes use of a long-range correlated time series. The long-range correlation can be mapped to self-similar calculations through simple integration.
Time frame: Pre- (40 minutes before) and Post- (40 minutes after) -Intervention
Corticospinal Excitability Measured by Motor Evoked Potential Amplitude
Conducted using Spike2 software (version 10; Cambridge Electronic Design, Cambridge, United Kingdom) and subsequently exported to, MATLAB R2018a (The MathWorks, Natick, Massachusetts, United States) for processing and analysis. Corticospinal Excitability will be quantified as the peak-to-peak amplitude of MEPs elicited by a single-pulse TMS stimulus, with values averaged across 10 trials per participant.
Time frame: Baseline (Pre) and immediately after the intervention (Post)
Cortical Silent Period (SP) Duration
Silent period will be calculated as the time from MEP onset to the resumption of voluntary EMG activity, expressed as SP = resumption of voluntary EMG time - MEP onset (58), and averaged across all 10 stimuli.
Time frame: Baseline (Pre) and immediately after the intervention (Post)
Intracortical Facilitation (ICF)
ICF will be determined using the same calculation method but with an interstimulus interval of 12 ms (ICF = conditioned MEP / control MEP).
Time frame: Baseline (Pre) and immediately after the intervention (Post)
Short-Interval Intracortical Inhibition (SICI)
SICI will be calculated as the ratio between the conditioned MEP elicited with a paired-pulse TMS protocol (interstimulus interval: 3 ms) and a control MEP obtained from AMT assessment, expressed as SICI = conditioned MEP / control MEP.
Time frame: Baseline (Pre) and immediately after the intervention (Post)
Magnitude of variability
Calculate the coefficient of variation of inter-stride intervals, representing the magnitude of variability.
Time frame: Pre- (40 minutes before) and Post- (40 minutes after) -Intervention
Synchronization Accuracy
Asynchronies (ASYNC), i.e., the time difference between the heel strikes and the cues, expressed in milliseconds. This will be used to ensure that differences at the primary outcome are not the result of different synchronization performances. A negative value of ASYNC indicates that the heel strike occurred before the cue. The ASYNC provides information regarding the strategies used and the performance of the synching processes, serving as a control parameter to reliably interpret our results in terms of gait complex.
Time frame: During Intervention
Demographic characterization of the sample by Lysholm Knee Score (LKS).
The LKS show good internal consistency (Cronbach's α = 0.802) and high test-retest reliability (ICC = 0.859). The LKS consists of 8 items with 3 to 6 closed-response options, assessing knee function aspects such as pain, swelling, locking, and instability. The scale is completed in ≈5 minutes, with higher scores indicating better knee function.
Time frame: At the beginning of the first session (Day 1)
Demographic characterization of the sample by Tegner Activity Scale (TAS)
The TAS show good internal consistency (Cronbach's α = 0.802) and high test-retest reliability (ICC = 0.972). The TAS comprises a single item with 11 activity levels (0-10), reflecting increasing physical demand. The scale is completed in ≈2 minutes, with higher scores indicating greater physical activity levels (TAS).
Time frame: At the beginning of the first session (Day 1)
Demographic characterization of the sample by Tampa Scale of Kinesiophobia (TSK)
The TSK consists of 13 items rated on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree), with a total score ranging from 13 to 52, where higher scores indicate greater kinesiophobia. It required 4 to 6 minutes to complete the instrument and demonstrated good internal consistency (α = 0.82) and test-retest reliability (ICC = 0.99), confirming its reliability for assessing kinesiophobia.
Time frame: At the beginning of the first session (Day 1)
Plan to share: Yes — All raw data will be stored in the supervisor's institutional personal Microsoft 365 account for five years, after which it will be permanently deleted. Data will be recorded anonymously using a unique coded numerical ID, known only to the supervisor. The database will be in Excel format. The encoded dataset may be shared with the rest of the research team and the journal where the study will be published, which may, in turn, make the data available to the scientific community for one year following publication.
Started Oct 2025 (actual). Primary completion is estimated for Nov 2026, 13 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Egas Moniz - Cooperativa de Ensino Superior, CRL